Researchers at São Paulo State University's Botucatu Institute of Biosciences (IBB-UNESP) in Brazil have developed a novel biomaterial that speeds up osteoblast (bone cell) differentiation. The invention has the potential ...
Nov 21, 2023
0
17
The treatment of moderately active rheumatoid arthritis with the tumour necrosis factor inhibitor Etanercept achieves excellent success in more than 80 per cent of patients. With this method, the success can be maintained ...
Jan 18, 2013
0
0
Toxicity problems and adverse side effects when taking lithium, the mainstay medication for treating bipolar disorder, are fostering a scientific hunt for insights into exactly how lithium works in the body—with an eye ...
Mar 27, 2013
0
0
New hope has arrived for migraine sufferers following a Griffith University study with the people of Norfolk Island.
Jun 4, 2012
0
1
Lisbon, Portugal: Patients with advanced breast cancer who are treated with a combination of drugs that target specific molecules important for cancer development and also the hormones that are driving it are at increased ...
Nov 2, 2017
0
2
A one-two punch of changing gene expression, then deploying immune checkpoint inhibitors, shows promise in battling one of the most treatment-resistant types of cancer in preclinical models, according to a new publication ...
Sep 30, 2020
0
8
More than 30 million people in the United States wrongly believe they are allergic to penicillin—resulting in millions of dollars in added health care costs, adverse side effects from the use of more powerful antibiotics ...
Oct 29, 2019
1
1
A novel therapy using two targeted treatments for prostate cancer has been shown to maximize efficacy while reducing side effects according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) ...
Jun 25, 2019
0
3
Researchers have developed a genetic test that can identify how patients with triple negative early-stage breast cancer will respond to immunotherapy drugs. This means that patients who are unlikely to respond to these drugs ...
Mar 19, 2024
0
7
(HealthDay)—Immune checkpoint inhibitor (ICI) treatment is associated with increased cardiac events among patients with lung cancer and malignant melanoma, according to a study published online Dec. 9 in the European Heart ...
Dec 18, 2020
0
5
